State of Wisconsin Investment Board’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.02M Sell
33,275
-732
-2% -$160K 0.02% 795
2026
Q1
$6.43M Sell
34,007
-505
-1% -$88.3K 0.01% 889
2025
Q4
$5.87M Sell
34,512
-2,528
-7% -$388K 0.01% 944
2025
Q3
$4.88M Buy
37,040
+26
+0.1% +$3.12K 0.01% 972
2025
Q2
$3.93M Sell
37,014
-2,219
-6% -$241K 0.01% 1018
2025
Q1
$4.87M Sell
39,233
-975
-2% -$127K 0.01% 943
2024
Q4
$4.95M Sell
40,208
-1,336
-3% -$157K 0.01% 950
2024
Q3
$4.63M Hold
41,544
0.01% 983
2024
Q2
$4.43M Buy
41,544
+8,466
+26% +$931K 0.01% 981
2024
Q1
$3.98M Buy
33,078
+924
+3% +$113K 0.01% 1029
2023
Q4
$3.95M Sell
32,154
-1,973
-6% -$246K 0.01% 1064
2023
Q3
$4.42M Buy
34,127
+1,148
+3% +$153K 0.01% 976
2023
Q2
$4.09M Sell
32,979
-399
-1% -$53.7K 0.01% 1054
2023
Q1
$4.88M Sell
33,378
-23,788
-42% -$3.52M 0.01% 972
2022
Q4
$9.11M Buy
57,166
+21,128
+59% +$3.1M 0.03% 614
2022
Q3
$4.8M Sell
36,038
-32,748
-48% -$4.98M 0.02% 965
2022
Q2
$10.7M Buy
68,786
+16,786
+32% +$2.58M 0.03% 607
2022
Q1
$8.1M Sell
52,000
-38,529
-43% -$5.59M 0.02% 906
2021
Q4
$11.5M Buy
90,529
+19,721
+28% +$2.59M 0.02% 720
2021
Q3
$9.22M Buy
70,808
+1,509
+2% +$228K 0.02% 798
2021
Q2
$12.3M Buy
69,299
+40,804
+143% +$7.07M 0.03% 661
2021
Q1
$4.68M Sell
28,495
-656
-2% -$108K 0.01% 1043
2020
Q4
$4.81M Sell
29,151
-2,580
-8% -$384K 0.01% 996
2020
Q3
$4.52M Sell
31,731
-190
-0.6% -$23.6K 0.01% 972
2020
Q2
$3.52M Buy
31,921
+1,830
+6% +$202K 0.01% 984
2020
Q1
$3M Sell
30,091
-9,700
-24% -$1.25M 0.01% 959
2019
Q4
$5.94M Buy
39,791
+5,687
+17% +$774K 0.01% 890
2019
Q3
$4.37M Sell
34,104
-15,714
-32% -$2.11M 0.01% 845
2019
Q2
$7.1M Sell
49,818
-25,113
-34% -$3.37M 0.02% 726
2019
Q1
$10.7M Buy
74,931
+15,895
+27% +$2.07M 0.03% 589
2018
Q4
$7.32M Sell
59,036
-9,430
-14% -$1.4M 0.02% 652
2018
Q3
$11.5M Sell
68,466
-466
-0.7% -$80.1K 0.03% 574
2018
Q2
$11.9M Buy
68,932
+10,752
+18% +$1.76M 0.03% 563
2018
Q1
$8.79M Buy
58,180
+16,680
+40% +$2.45M 0.03% 683
2017
Q4
$5.59M Sell
41,500
-844
-2% -$117K 0.02% 834
2017
Q3
$6.19M Buy
+42,344
New +$6.4M 0.02% 786
2017
Q2
Sell
-26,340
Closed -$3.82M 1473
2017
Q1
$3.82M Buy
+26,340
New +$3.43M 0.01% 828
2016
Q2
Sell
-11,410
Closed -$1.49M 1327
2016
Q1
$1.49M Sell
11,410
-33,860
-75% -$4.21M 0.01% 1147
2015
Q4
$6.36M Sell
45,270
-340
-0.7% -$47.1K 0.02% 678
2015
Q3
$6.06M Sell
45,610
-1,260
-3% -$217K 0.02% 696
2015
Q2
$8.25M Buy
46,870
+1,770
+4% +$318K 0.03% 635
2015
Q1
$7.79M Sell
45,100
-1,240
-3% -$213K 0.03% 654
2014
Q4
$7.59M Buy
46,340
+2,650
+6% +$440K 0.03% 654
2014
Q3
$7.01M Buy
43,690
+290
+0.7% +$44.6K 0.03% 677
2014
Q2
$6.38M Buy
43,400
+6,320
+17% +$876K 0.02% 733
2014
Q1
$5.14M Buy
37,080
+60
+0.2% +$9.03K 0.02% 796
2013
Q4
$4.68M Sell
37,020
-1,110
-3% -$115K 0.02% 813
2013
Q3
$3.51M Sell
38,130
-2,960
-7% -$239K 0.01% 894
2013
Q2
$2.82M Buy
+41,090
New +$2.51M 0.01% 993

Other funds holding JAZZ

State of Wisconsin Investment Board's JAZZ Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.2% in Q2 2026, selling an estimated $160K and leaving 33,275 shares worth $8.02M. The position accounts for 0.02% of the portfolio, ranked #795.

State of Wisconsin Investment Board first reported a position in JAZZ in Q2 2013 and has held it in 49 quarters since. The position peaked at $12.3M in Q2 2021. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • State of Wisconsin Investment Board held 33,275 shares of Jazz Pharmaceuticals worth $8.02M as of Q2 2026.
  • State of Wisconsin Investment Board sold 732 Jazz Pharmaceuticals shares in Q2 2026, an estimated $160K.
  • Jazz Pharmaceuticals made up 0.02% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #795 holding.
  • State of Wisconsin Investment Board first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • State of Wisconsin Investment Board's Jazz Pharmaceuticals position peaked at $12.3M in Q2 2021.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.